The multi-disciplinary Cardiac Amyloidosis Clinical Center at University of Pittsburgh and University of Pittsburgh Medical Center (UPMC) offers state-of-the-art diagnosis and management of patients with cardiac amyloidosis.  The Center serves a growing need for clinical care and research driven by the recent recognition of a high prevalence of cardiac amyloidosis, made possible by developments in non-invasive cardiac imaging.

The clinic provides consultative services to:

• facilitate the diagnosis, typing (differentiation of ATTR from AL) and characterization of suspected or known cardiac amyloidosis

• evaluate patients for multi-system involvement

• identify patients suitable for currently available off-label therapies for cardiac ATTR amyloidosis, and for clinical trials. There are several specific therapies for amyloid cardiomyopathy and neuropathy that are close to clinical translation.

• facilitate participation in the cardiac amyloidosis registry and biobank